Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 2/2019

Open Access 01-02-2019 | Original Article

Perceptions of Dutch health care professionals on weight gain during chemotherapy in women with breast cancer

Authors: J. Th. C. M. de Kruif, M. B. Scholtens, J. van der Rijt, M. R. de Boer, M. M. G. A. van den Berg, Y. C. de Vries, R. M. Winkels, M. Visser, E. Kampman, M. J. Westerman

Published in: Supportive Care in Cancer | Issue 2/2019

Login to get access

Abstract

Purpose

Dutch Health care professionals (HCPs) provide little information concerning health risks associated with weight gain during chemotherapy for breast cancer. Women with breast cancer have specified the need for more information on nutrition and physical activity to deal with weight gain. The aims of this study were to assess the perceptions of Dutch HCPs on weight gain during chemotherapy and in addition evaluate whether and what kind of information on dietary intake and physical activity HCPs provide to prevent/treat weight gain during (neo)adjuvant chemotherapy.

Methods

A qualitative study was conducted using semi-structured interviews with 34 HCPs involved in breast cancer care: general practitioners, oncologists, specialized nurses, and dieticians.

Results

To date, little information about nutrition, physical activity, and weight gain is given during chemotherapy because it is not part of most HCPs’ training, it is not included in the guidelines and it is not the best time to bring up information in the opinion of HCPs. Weight gain was perceived as just a matter of a few kilos and not an important health issue during treatment. All HCPs felt it is better that women themselves addressed their weight gain after chemotherapy.

Conclusion

More knowledge about health risks associated with chemotherapy-induced weight gain and how to combat these issues needs to be made readily available to the HCPs and should become part of their training. Existing patient guidelines should include information on how to prevent and/or reduce weight gain through self-management of nutrition intake and physical activity during and post chemotherapy.
Literature
1.
Rosso S, Gondos A, Zanetti R, Bray F, Zakelj M, Zagar T, Smailyte G, Ponti A, Brwester DH, Voogd AC, Crocetti E, Brenner H, the EUNICE Survival Working Group (2010) Up-to-date estimates of breast cancer survival for the years 2000–2004 in 11 European countries: the role of screening and a comparison with data from the United States. Eur J Cancer 46:3351–3357PubMedCrossRef
2.
Sukel MPP, Van de Poll-Franse LV, Nieuwenhuijzen GP, Vreugdenhil G, Herings RMC, Coebergh JWW (2008) Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern Netherlands. Eur J Cancer 13:1846–1854CrossRef
3.
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2012) Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 379:432–444CrossRef
4.
Berrino F, De Angelis R, Sant M, Rosso S, Lasota MB, Coebergh JW, Santaquilani M, the EUROCARE Working group (2007) Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study. Lancet Oncol 9:773–783CrossRef
5.
Verdecchia A, Guzzinati S, Francisci S, De Angelis R, Bray F, Allemani C (2009) Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer 6:1042–1066CrossRef
6.
Mauri D, Polyzos NP, Salant G, Pavlidis N, Ioannidis JP (2008) Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer. J Natl Cancer Inst 100:1780–1791PubMedCrossRef
7.
Heideman WH, Russell NS, Gundy C, Rookus MA, Voskuil DW (2009) The frequency, magnitude and timing of post-diagnosis body weight gain in Dutch breast cancer survivors. Eur J Cancer 45(1):119–126PubMedCrossRef
8.
Villarini A, Pasanisi P, Raimondi M, Gargano G, Bruno E, Morelli D (2012) Preventing weight gain during adjuvant chemotherapy for breast cancer: a dietary intervention study. Breast Cancer Res Treat 135:581–589PubMedCrossRef
9.
Demark-Wahnefried W, Rimer BK, Winer EP (1997) Weight gain in women diagnosed with breast cancer. J Am Diet Assoc 97:519–526PubMedCrossRef
10.
Vance V, Mourtzakis M, McCargar L, Hanning R (2011) Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev 12:282–294PubMedCrossRef
11.
Yaw YH, Shariff ZM, Kandiah M, Mun CY, Yusof RM, Othman Z, Saibul N, Weay YH, Hashim Z (2011) Weight changes and lifestyle behaviors in women after breast cancer diagnosis: a cross-sectional study. BMC Public Health 11(1):309PubMedPubMedCentralCrossRef
12.
Freedman RJ (2004) Weight and body composition changes during and after adjuvant chemotherapy in women with breast Cancer. J Clin Endocrinol Metab 89:2248–2253PubMedCrossRef
13.
Kroenke CH, Chen WY, Rosner B, Holmes MD (2005) Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 23:1370–1378PubMedCrossRef
14.
Caan BJ, Emond J, Natarajan L, Castillo A, Gunderson EP, Habel L (2006) Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat 99(1):47–57PubMedCrossRef
15.
Herman DR, Ganz PA, Petersen L, Greendale GA (2005) Obesity and cardiovascular risk factors in younger breast cancer survivors: the cancer and menopause study (CAMS). Breast Cancer Res Treat 93(1):13–23PubMedCrossRef
16.
Muraca L, Leung D, Clark A, Beduz MA, Goodwin P (2011) Breast cancer survivors: taking charge of lifestyle choices after treatment. Eur J Oncol Nurs 3:250–253CrossRef
17.
Gandhi M, Oishi K, Zubal B, Lacouture ME (2010) Unanticipated toxicities from anticancer therapies: survivors’ perspectives. Support Care Cancer 18(11):1461–1468PubMedCrossRef
18.
Avis NE, Crawford S, Manuel J (2004) Psychosocial problems among younger women with breast cancer. Psycho-Oncology 13(5):295–308PubMedCrossRef
19.
Weathers B, Barg FK, Collier A, Halbert CH (2006) Perceptions of changes in weight among African American breast cancer survivors. Psycho-Oncology 15(2):174–179PubMedCrossRef
20.
Cappiello M, Cunningham RS, Knobf MT, Erdos D (2007) Breast cancer survivors: information and support after treatment. Clin Nurs Res 16(4):278–293 discussion 294–301PubMedCrossRef
21.
22.
Binkley JM, Harris SR, Levangie PK, Pearl M, Guglielmino J, Kraus V, Rowden D (2012) Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer. Cancer 118(8 Suppl):2207–2216PubMedCrossRef
23.
Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM (2005) Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 23(24):5814–5830PubMedPubMedCentralCrossRef
24.
Jones LW, Courneya KS, Fairey AS, Mackey JR (2004) Effects of an oncologist’s recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a single-blind, randomized controlled trial. Ann Behav Med 28(2):105–113PubMedCrossRef
25.
Demark-Wahnefried W, Case LD, Blackwell K, Marcom PK, Kraus W, Aziz N, Snyder DC, Giguere JK, Shaw E (2008) Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy. Clin Breast Cancer 8(1):70–79PubMedCrossRef
26.
Cheema BSB, Gaul CA (2006) Full-body exercise training improves fitness and quality of life in survivors of breast cancer. J Strength Cond Res 20(1):14–21PubMed
27.
Ohira T, Schmitz KH, Ahmed RL, Yee D (2006) Effects of weight training on quality of life in recent breast cancer survivors: the weight training for breast cancer survivors (WTBS) study. Cancer 106(9):2076–2083PubMedCrossRef
28.
Visovsky C (2006) Muscle strength, body composition, and physical activity in women receiving chemotherapy for breast cancer. Integr Cancer Ther 5(3):183–191PubMedCrossRef
29.
Swinburn B, Caterson I, Seidell J, James W (2007) Diet, nutrition and the prevention of excess weight gain and obesity. Public Health Nutr 7(1a):123–146
30.
Speck RM, Courneya KS, Mâsse LC, Duval S, Schmitz KH (2010) An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 4(2):87–100PubMedCrossRef
31.
Waart H van, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, Aaronson NK (2015) Effect of low-intensity physical activity and moderate-to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol (17):1918–1927
32.
van den Berg MMGA (2017) Changes in body composition as a result of chemotherapy. Dissertation Wageningen University, The Netherlands
33.
34.
Braun V, Clarcke V (2013) Successful qualitative research. Sage Publications Ltd.
35.
36.
Harrison JD, Young JM, Price M, Butow PN, Solomon MJ (2009) What are the unmet supportive care needs of people with cancer? A systematic review. Support Care Cancer 8:1117–1128CrossRef
37.
38.
Chlebowski RT (2013) Nutrition and physical activity influence on breast cancer incidence and outcome. Breast 22:S30–S37PubMedCrossRef
39.
40.
41.
Demark-Wahnefried W, Kenyon AJ, Eberle P, Skye A, Kraus WE (2002) Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study. Clin Exerc Physiol 4(1):44–49PubMedPubMedCentral
42.
Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, Bandera EV, Hamilton KK, Grant B, McCullough M, Byers T, Gansler T (2012) Cancer nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62:242–274CrossRef
43.
Demark-Wahnefried W, Rogers LQ, Alfano CM, Thomson CA, Courneya KS, Meyerhardt JA, Stout NL, Kvale E, Ganzer H, Ligibel JA (2015) Practical clinical interventions for diet, physical activity, and weight control in Cancer survivors. CA Cancer J Clin 65:167–189PubMedCrossRef
44.
45.
Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hütterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Mühlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC (2017) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36(1):11–48PubMedCrossRef
Metadata
Title
Perceptions of Dutch health care professionals on weight gain during chemotherapy in women with breast cancer
Authors
J. Th. C. M. de Kruif
M. B. Scholtens
J. van der Rijt
M. R. de Boer
M. M. G. A. van den Berg
Y. C. de Vries
R. M. Winkels
M. Visser
E. Kampman
M. J. Westerman
Publication date
01-02-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 2/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4347-2

Other articles of this Issue 2/2019

Supportive Care in Cancer 2/2019 Go to the issue

Original Article

A prospective and population-based inquiry on the use and acceptability of peer support for women newly diagnosed with breast cancer

Original Article

Accuracy of the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) score as an objective assessment tool for predicting return-to-work status after head and neck cancer in male survivors

Correction

Correction to: The impact of social-emotional context in chronic cancer pain: patient-caregiver reverberations

Original Article

Patients’ experience of lung cancer care coordination: a quantitative exploration

Original Article

Clinical and epidemiological factors associated with suicide in colorectal cancer

Review Article

Exploring the spectrum of late effects following radical orchidectomy for stage I testicular seminoma: a systematic review of the literature
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits